Clinical Trial Update: Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a shortened benznidazole regimen for chronic-phase Chagas disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Drugs mentioned

• Benznidazole (benznidazole)

Snippet

Sponsor: Evandro Chagas Institute of Clinical Research | Conditions: Chronic Chagas Disease | Phase 3 | Status: WITHDRAWN